Patents

US 11458109 B2: Treatment of 22Q11.2 deletion syndrome with cannabidiol

Granted
2022-10-04
Filed
2019-12-12 application 16712066
Type
Utility · 15 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present technology relates to methods of treating one or more behavioral symptoms (for example, anxiety) of 22q11.2 deletion syndrome in a subject by administering, e.g., transdermally, an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of 22q11.2 deletion syndrome are treated in the subject.

Source: PVGPATDIS, file of 2026-04-10 (ipg221004.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
ZYNERBA PHARMACEUTICALS, INC. 13 patentsUS company or organizationDevon, PAZYNERBA PHARMACEUTICALS, INC. Federal lobbying client EXACT high confidence: identical full name and state
ZYNERBA PHARMACEUTICALS, INC. SEC filer EXACT medium confidence: identical full name, one of each nationally
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Terri SebreeGladwyne, PA27PVGPATDIS, file of 2026-04-10
Donna GuttermanRaleigh, NC14PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/035PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P25/22PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2026-05-18Correction
Supplemental confirmatory grant of security interest in united states patents
HARMONY BIOSCIENCES MANAGEMENT, INC. (F/K/A ZYNERBA PHARMACEUTICALS, INC.) signed 2026-05-04JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT CHICAGO, IL75642/639PASDL, file of 2026-10-15
2019-12-13Assignment
Assignment of assignor's interest
SEBREE, TERRI signed 2019-12-11
GUTTERMAN, DONNA signed 2019-12-10
ZYNERBA PHARMACEUTICALS, INC. DEVON, PA51288/158PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.